Point-of-care Analysis for Non-invasive Diagnosis of Oral cancer (PANDORA): A technology-development proof of concept diagnostic accuracy study of dielectrophoresis in patients with oral squamous cell carcinoma and dysplasia.
diagnosis
dielectrophoresis
oral cancer
oral epithelial dysplasia
oral squamous cell carcinoma
Journal
Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology
ISSN: 1600-0714
Titre abrégé: J Oral Pathol Med
Pays: Denmark
ID NLM: 8911934
Informations de publication
Date de publication:
Apr 2023
Apr 2023
Historique:
received:
10
10
2022
accepted:
17
02
2023
medline:
6
4
2023
pubmed:
23
2
2023
entrez:
22
2
2023
Statut:
ppublish
Résumé
Delays in the identification and referral of oral cancer remain frequent. An accurate and non-invasive diagnostic test to be performed in primary care may help identifying oral cancer at an early stage and reduce mortality. Point-of-care Analysis for Non-invasive Diagnosis of Oral cancer (PANDORA) was a proof-of-concept prospective diagnostic accuracy study aimed at advancing the development of a dielectrophoresis-based diagnostic platform for oral squamous cell carcinoma (OSCC) and epithelial dysplasia (OED) using a novel automated DEPtech 3DEP analyser. The aim of PANDORA was to identify the set-up of the DEPtech 3DEP analyser associated with the highest diagnostic accuracy in identifying OSCC and OED from non-invasive brush biopsy samples, as compared to the gold standard test (histopathology). Measures of accuracy included sensitivity, specificity, positive and negative predictive value. Brush biopsies were collected from individuals with histologically proven OSCC and OED, histologically proven benign mucosal disease, and healthy mucosa (standard test), and analysed via dielectrophoresis (index test). 40 individuals with OSCC/OED and 79 with benign oral mucosal disease/healthy mucosa were recruited. Sensitivity and specificity of the index test was 86.8% (95% confidence interval [CI], 71.9%-95.6%) and 83.6% (95% CI, 73.0%-91.2%). Analysing OSCC samples separately led to higher diagnostic accuracy, with 92.0% (95% CI, 74.0%-99.0%) sensitivity and 94.5% (95% CI, 86.6%-98.5%) specificity. The DEPtech 3DEP analyser has the potential to identify OSCC and OED with notable diagnostic accuracy and warrants further investigation as a potential triage test in the primary care setting for patients who may need to progress along the diagnostic pathway and be offered a surgical biopsy.
Sections du résumé
BACKGROUND
BACKGROUND
Delays in the identification and referral of oral cancer remain frequent. An accurate and non-invasive diagnostic test to be performed in primary care may help identifying oral cancer at an early stage and reduce mortality. Point-of-care Analysis for Non-invasive Diagnosis of Oral cancer (PANDORA) was a proof-of-concept prospective diagnostic accuracy study aimed at advancing the development of a dielectrophoresis-based diagnostic platform for oral squamous cell carcinoma (OSCC) and epithelial dysplasia (OED) using a novel automated DEPtech 3DEP analyser.
METHODS
METHODS
The aim of PANDORA was to identify the set-up of the DEPtech 3DEP analyser associated with the highest diagnostic accuracy in identifying OSCC and OED from non-invasive brush biopsy samples, as compared to the gold standard test (histopathology). Measures of accuracy included sensitivity, specificity, positive and negative predictive value. Brush biopsies were collected from individuals with histologically proven OSCC and OED, histologically proven benign mucosal disease, and healthy mucosa (standard test), and analysed via dielectrophoresis (index test).
RESULTS
RESULTS
40 individuals with OSCC/OED and 79 with benign oral mucosal disease/healthy mucosa were recruited. Sensitivity and specificity of the index test was 86.8% (95% confidence interval [CI], 71.9%-95.6%) and 83.6% (95% CI, 73.0%-91.2%). Analysing OSCC samples separately led to higher diagnostic accuracy, with 92.0% (95% CI, 74.0%-99.0%) sensitivity and 94.5% (95% CI, 86.6%-98.5%) specificity.
CONCLUSION
CONCLUSIONS
The DEPtech 3DEP analyser has the potential to identify OSCC and OED with notable diagnostic accuracy and warrants further investigation as a potential triage test in the primary care setting for patients who may need to progress along the diagnostic pathway and be offered a surgical biopsy.
Substances chimiques
Biomarkers, Tumor
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
305-314Subventions
Organisme : Invention for Innovation Programme
Organisme : National Institute for Health Research
Organisme : UCLH Biomedical Research Centre
Informations de copyright
© 2023 The Authors. Journal of Oral Pathology & Medicine published by John Wiley & Sons Ltd.
Références
Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209-249.
Marur S, D'Souza G, Westra WH, Forastiere AA. HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol. 2010;11(8):781-789.
Mignogna MD, Fedele S, Lo Russo L. The world cancer report and the burden of oral cancer. Eur J Cancer Prev. 2004;13(2):139-142.
Gómez I, Seoane J, Varela-Centelles P, Diz P, Takkouche B. Is diagnostic delay related to advanced-stage oral cancer? A meta-analysis. Eur J Oral Sci. 2009;117(5):541-546.
Pitchers M, Martin C. Delay in referral of oropharyngeal squamous cell carcinoma to secondary care correlates with a more advanced stage at presentation, and is associated with poorer survival. Br J Cancer. 2006;94(7):955-958.
Kowalski LP, Franco EL, Torloni H, et al. Lateness of diagnosis of oral and oropharyngeal carcinoma: factors related to the tumour, the patient and health professionals. Eur J Cancer B Oral Oncol. 1994;30B(3):167-173.
Walsh T, Macey R, Kerr AR, Lingen MW, Ogden GR, Warnakulasuriya S. Diagnostic tests for oral cancer and potentially malignant disorders in patients presenting with clinically evident lesions. Cochrane Database Syst Rev. 2021;7(7):CD010276.
Bossuyt PM, Irwig L, Craig J, Glasziou P. Comparative accuracy: assessing new tests against existing diagnostic pathways [published correction appears in BMJ. 2006 Jun 10;332(7554):1368]. BMJ. 2006;332(7549):1089-1092.
Langton S, Siau D, Bankhead C. Two-week rule in head and neck cancer 2000-14: a systematic review. Br J Oral Maxillofac Surg. 2016;54(2):120-131.
Pethig R. Review article-dielectrophoresis: status of the theory, technology, and applications. Biomicrofluidics. 2010;4(2):022811.
Broche LM, Labeed FH, Hughes MP. Extraction of dielectric properties of multiple populations from dielectrophoretic collection spectrum data. Phys Med Biol. 2005;50(10):2267-2274.
Gascoyne PR, Wang XB, Huang Y, Becker FF. Dielectrophoretic separation of cancer cells from blood. IEEE Trans Ind Appl. 1997;33(3):670-678.
An J, Lee J, Lee SH, Park J, Kim B. Separation of malignant human breast cancer epithelial cells from healthy epithelial cells using an advanced dielectrophoresis-activated cell sorter (DACS). Anal Bioanal Chem. 2009;394(3):801-809.
Salmanzadeh A, Kittur H, Sano MB, C Roberts P, Schmelz EM, Davalos RV. Dielectrophoretic differentiation of mouse ovarian surface epithelial cells, macrophages, and fibroblasts using contactless dielectrophoresis. Biomicrofluidics. 2012;6(2):24104-2410413.
Chin S, Hughes MP, Coley HM, Labeed FH. Rapid assessment of early biophysical changes in K562 cells during apoptosis determined using dielectrophoresis. Int J Nanomedicine. 2006;1(3):333-337.
Mulhall HJ, Labeed FH, Kazmi B, Costea DE, Hughes MP, Lewis MP. Cancer, pre-cancer and normal oral cells distinguished by dielectrophoresis. Anal Bioanal Chem. 2011;401(8):2455-2463.
Liang X, Graham KA, Johannessen AC, Costea DE, Labeed FH. Human oral cancer cells with increasing tumorigenic abilities exhibit higher effective membrane capacitance. Integr Biol (Camb). 2014;6(5):545-554.
Mulhall HJ, Hughes MP, Kazmi B, Lewis MP, Labeed FH. Epithelial cancer cells exhibit different electrical properties when cultured in 2D and 3D environments. Biochim Biophys Acta. 2013;1830(11):5136-5141.
Graham KA, Mulhall HJ, Labeed FH, et al. A dielectrophoretic method of discrimination between normal oral epithelium, and oral and oropharyngeal cancer in a clinical setting. Analyst. 2015;140(15):5198-5204.
Hoettges KF, Henslee EA, Torcal Serrano RM, et al. Ten-second electrophysiology: evaluation of the 3DEP platform for high-speed, high-accuracy cell analysis. Sci Rep. 2019;9(1):19153.
Ismail A, Hughes MP, Mulhall HJ, Oreffo RO, Labeed FH. Characterization of human skeletal stem and bone cell populations using dielectrophoresis. J Tissue Eng Regen Med. 2015;9(2):162-168.
Beale AD, Kruchek E, Kitcatt SJ, et al. Casein kinase 1 underlies temperature compensation of circadian rhythms in human red blood cells. J Biol Rhythms. 2019;34(2):144-153.
Cohen JF, Korevaar DA, Altman DG, et al. STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration. BMJ Open. 2016;6(11):e012799.
El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ. WHO classification of head and neck tumours. WHO Classification of Tumours. Vol 9, 9. 4th ed. IARC Press; 2015:109-112.
Carley S, Dosman S, Jones SR, Harrison M. Simple nomograms to calculate sample size in diagnostic studies [published correction appears in Emerg Med J. 2005 May;22(5):392]. Emerg Med J. 2005;22(3):180-181.
Fatoyinbo HO, Kadri NA, Gould DH, Hoettges KF, Labeed FH. Real-time cell electrophysiology using a multi-channel dielectrophoretic-dot microelectrode array. Electrophoresis. 2011;32(18):2541-2549.
Hoque R, Mostafid H, Hughes MP. Rapid, low-cost dielectrophoretic diagnosis of bladder cancer in a clinical setting. IEEE J Transl Eng Health Med. 2020;8:4300405.
Richter I, Alajbeg I, Boras VV, Rogulj AA, Brailo V. Mapping electrical impedance spectra of the healthy oral mucosa: a pilot study. Acta Stomatol Croat. 2015;49(4):331-339.
Trevethan R. Sensitivity, specificity, and predictive values: foundations, Pliabilities, and pitfalls in research and practice. Front Public Health. 2017;5:307.
Lim K, Moles DR, Downer MC, Speight PM. Opportunistic screening for oral cancer and precancer in general dental practice: results of a demonstration study. Br Dent J. 2003;194(9):493-497.